Phenazocine

This classification denotes an opioid analgesic and narcotic with the molecular formula C22H27NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier J0ND6N0AQC, chemically known as 1,2,3,4,5,6-hexahydro-8-hydroxy-6,11-dimethyl-3-phenethyl-2,6-methano-3-benzazocine but generally known as phenazocine, which bears US NIH Compound Identifier 14707. European Medicines Agency schedules Phenazocine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09752MIG. World Health Organization schedules phenazocine in its Anatomical Therapeutic Chemical (ATC) Classification. PHENAZOCINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule phenazocine under HS 29333999 and SITC 51574. As of Q4 2014, PHENAZOCINE remains the US FDA Preferred Term for this commodity. Phenazocine bears US NLM identifiers UMLS ID C0031376 and NCI Concept Code C96728. SMILES: OC1CC2C3(C(C(N(CC3)CCC3CCCCC3)CC2CC1)C)C.